摘要
桂枝汤作为《伤寒论》开宗明义第一方,被誉为“群方之冠”,凡学习中医之人几乎没有不从桂枝汤入门的。中医治疗上,桂枝可用于发热、关节痛、头痛、腹痛、下痢、头昏、遗精、心悸、浮肿、瘀血、耳鸣等病证。桂枝的药效并不单一,适用范围很广。可以说,桂枝是中医最难用的药物之一,也是颇具魅力的药物之一。张机(字仲景)在其所著《伤寒论》和《金匮要略》两书中,取桂枝汤之意加减化裁的系列方剂有26首,可见其地位的重要性。文章从桂枝汤的病机、结构、服法禁忌、争议等方面入手论述桂枝汤,旨在为临床运用桂枝汤提供参考和借鉴。
The Guizhi decoction(桂枝汤),as the first prescription in Shanghan Lun(《伤寒论》),is known as“the crown of the prescription group”.No people who learn TCM almost do not start from the Guizhi decoction.In TCM,Guizhi(Ramulus cinnamomi)can be used for treating fever,joint pain,headache,abdominal pain,dysentery,dizziness,spermatorrhea,palpitations,edema,blood stasis,tinnitus and other diseases.The efficacy of Guizhi is not single,the applicable range is very wide.It can be said that Guizhi is one of the most difficult drugs used in TCM,but also one of the most attractive drugs.In ZHANG Zhongjing’s Shanghan Lun and Jin’gui Yaolue(《金匮要略》),there are 26 prescriptions with the meaning of the Guizhi decoction,which shows its important status.The Guizhi decoction is discussed from the aspects of pathogenesis,structure,taboos,controversy,aiming to provide a reference for the clinical treatment.
作者
黄华生
刘腾
詹晨光
李婧斓
邵洋
杨志东
张顺聪
HUANG Huasheng;LIU Teng;ZHAN Chenguang;LI Jinglan;SHAO Yang;YANG Zhidong;ZHANG Shuncong
出处
《中医临床研究》
2022年第21期143-145,共3页
Clinical Journal Of Chinese Medicine
基金
广东省中医药局科研项目(20203004)
广东省自然基金项目(2021A1515012168)
高水平医院建设项目(211010010732)
广东省基础与应用基础研究基金项目(2020A1515110948)
广州市科技局基础与应用基础项目(202102021040)。
关键词
桂枝汤
《伤寒论》
表虚
争议
The Guizhi decoction
Shanghan Lun
Surface deficiency
Controversy
